ZOLPIDEM TARTRATE
- Product NDC
- 61919-955
- 11-digit product format
- 619190955
- Labeler code
- 61919
- Product ID
- 61919-955_bf1b22fc-d0f1-4204-a1f5-4302c0676616
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ZOLPIDEM TARTRATE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA090107
- Marketing category
- ANDA
- Marketing start
- 2014-01-01
- Marketing end
- 0000-00-00
- Substance
- ZOLPIDEM TARTRATE
- Active strength
- 13 mg/1
- Pharmacologic classes
- gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [CS],Central Nervous System Depression [PE]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-955-30 | ZOLPIDEM TARTRATE | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 4 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ZOLPIDEM TARTRATE | ACTIVE INGREDIENT | WY6W63843K | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | |
| ZOLPIDEM | ACTIVE MOIETY | 7K383OQI23 | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-955 | ZOLPIDEM TARTRATE TABLET, EXTENDED RELEASE [DIRECT RX] | 4 | Legacy NDC, 1 package rows | 20151113_84db101f-3194-4a40-83e3-403df03dffe1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 61919-955-30 | 61919095530 | 30 in 1 BOTTLE | Historical |